We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$618M
AUM Growth
+$34.4M
Cap. Flow
-$12M
Cap. Flow %
-1.95%
Top 10 Hldgs %
23.3%
Holding
492
New
15
Increased
–
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$318K
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$259K
3
MAN icon
ManpowerGroup
MAN
+$241K
4
UHS icon
Universal Health Services
UHS
+$236K
5
IR icon
Ingersoll Rand
IR
+$225K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.1M
2
CTXS
Citrix Systems Inc
CTXS
+$2.08M
3
KLAC icon
KLA
KLAC
+$1.36M
4
ORCL icon
Oracle
ORCL
+$912K
5
ITW icon
Illinois Tool Works
ITW
+$745K

Sector Composition

Rank Sector Weight
1 Technology 23.28%
2 Healthcare 15.2%
3 Financials 13.94%
4 Industrials 12.19%
5 Consumer Discretionary 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPG icon
376
PPG Industries
PPG
$26.5B
$277K 0.04%
2,200
-4,500
-67% -$551K
NI icon
377
NiSource
NI
$20.6B
$274K 0.04%
10,000
– –
PKBK icon
378
Parke Bancorp
PKBK
$401M
$274K 0.04%
13,200
– –
VERV
379
DELISTED
Verve Therapeutics
VERV
$271K 0.04%
14,000
– –
ACAD icon
380
Acadia Pharmaceuticals
ACAD
$4.96B
$271K 0.04%
17,000
– –
BXP icon
381
Boston Properties
BXP
$11.2B
$270K 0.04%
4,000
– –
UNH icon
382
UnitedHealth
UNH
$375B
$265K 0.04%
500
– –
BECN
383
DELISTED
Beacon Roofing Supply, Inc.
BECN
$264K 0.04%
5,000
– –
DMC
384
Del Monte Corp
DMC
$1.4B
$262K 0.04%
10,000
– –
SUP
385
DELISTED
Superior Industries International
SUP
$262K 0.04%
62,000
– –
SIMO icon
386
Silicon Motion
SIMO
$8.36B
$260K 0.04%
4,000
– –
CMRE icon
387
Costamare
CMRE
$1.77B
$260K 0.04%
28,000
– –
ZBH icon
388
Zimmer Biomet
ZBH
$19B
$255K 0.04%
2,000
– –
INN
389
Summit Hotel Properties
INN
$739M
$253K 0.04%
35,100
– –
MAN icon
390
ManpowerGroup
MAN
$2.53B
$250K 0.04%
+3,000
New +$241K
WTTR icon
391
Select Water Solutions
WTTR
$2.77B
$249K 0.04%
27,000
– –
HSTM icon
392
HealthStream
HSTM
$818M
$248K 0.04%
10,000
– –
NTLA icon
393
Intellia Therapeutics
NTLA
$1.53B
$248K 0.04%
7,100
– –
NUVA
394
DELISTED
NuVasive, Inc.
NUVA
$247K 0.04%
6,000
– –
CWK icon
395
Cushman & Wakefield Ltd
CWK
$3.29B
$247K 0.04%
19,800
– –
FTI icon
396
TechnipFMC
FTI
$27.2B
$244K 0.04%
20,000
– –
KYNB
397
Kyntra Bio
KYNB
$28.3M
$240K 0.04%
600
– –
HCA icon
398
HCA Healthcare
HCA
$88.7B
$240K 0.04%
+1,000
New +$224K
WWE
399
DELISTED
World Wrestling Entertainment
WWE
$240K 0.04%
3,500
– –
ALNY icon
400
Alnylam Pharmaceuticals
ALNY
$30.6B
$238K 0.04%
1,000
– –
14 15
16
17 18

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q4 2022 Portfolio in Review

As of Q4 2022, NJ State Employees Deferred Compensation Plan held 492 positions worth $618M, up 5.9% from $584M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.9%. NJ State Employees Deferred Compensation Plan opened 15 new positions and exited 9, leaving the 492-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • NJ State Employees Deferred Compensation Plan's largest Q4 2022 buy was Apellis Pharmaceuticals: 6,000 shares worth $310K.
  • NJ State Employees Deferred Compensation Plan's biggest Q4 2022 reduction was KLA, cutting an estimated $1.36M.
  • NJ State Employees Deferred Compensation Plan fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $3.1M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 23% of its $618M portfolio in Q4 2022.
  • NJ State Employees Deferred Compensation Plan opened 15 new positions and closed 9 in Q4 2022.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 5.9% quarter-over-quarter to $618M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2022, filed 26 Jan 2023.